The APOE4 allele, a major genetic risk factor for AD, impairs microglial Aβ clearance, promotes plaque formation, and disrupts lipid metabolism—further diminishing phagocytic efficiency [109,110]. This evidence concerns the gene APOE and Alzheimer disease.